Zobrazeno 1 - 10
of 161
pro vyhledávání: '"Stewart Gaede"'
Autor:
Laura Callan, Haddis Razeghi, Natalie Grindrod, Stewart Gaede, Eugene Wong, David Tan, Jason Vickress, John Patrick, Michael Lock
Publikováno v:
Current Oncology, Vol 31, Iss 10, Pp 5862-5872 (2024)
A Prognostic Index for Liver Radiation (PILiR) for improved patient selection for stereotactic liver-directed radiotherapy (SBRT) was developed. Using a large single-center database, 195 patients treated with SBRT for local control, including 66 with
Externí odkaz:
https://doaj.org/article/bbf28803ba7f4ebd900400a3ba11815a
Autor:
David A. Palma, Meredith E. Giuliani, Rohann J. M. Correa, Famke L. Schneiders, Stephen Harrow, Matthias Guckenberger, Tina Zhang, Houda Bahig, Sashendra Senthi, Peter Chung, Robert Olson, Michael Lock, Srinivas Raman, Glenn S. Bauman, Benjamin H. Lok, Joanna M. Laba, Rachel M. Glicksman, Timothy K. Nguyen, Pencilla Lang, Joelle Helou, Christopher D. Goodman, Lucas C. Mendez, Peter S. N. van Rossum, Andrew Warner, Stewart Gaede, Alison L. Allan
Publikováno v:
BMC Palliative Care, Vol 23, Iss 1, Pp 1-15 (2024)
Abstract Background Emerging randomized data, mostly from phase II trials, have suggested that patients with oligometastatic cancers may benefit from ablative treatments such as stereotactic ablative radiotherapy (SABR). However, phase III data testi
Externí odkaz:
https://doaj.org/article/2b8baa340960407cab86422d2a88489d
Autor:
Richard A. Malthaner, Edward Yu, Michael Sanatani, Debra Lewis, Andrew Warner, A. Rashid Dar, Brian P. Yaremko, Joel Bierer, David A. Palma, Dalilah Fortin, Richard I. Inculet, Eric Fréchette, Jacques Raphael, Stewart Gaede, Sara Kuruvilla, Jawaid Younus, Mark D. Vincent, George B. Rodrigues
Publikováno v:
Thoracic Cancer, Vol 13, Iss 13, Pp 1898-1915 (2022)
Abstract Background We compared the health‐related quality of life (HRQOL) in patients undergoing trimodality therapy for resectable stage I‐III esophageal cancer. Methods A total of 96 patients were randomized to standard neoadjuvant cisplatin a
Externí odkaz:
https://doaj.org/article/3b12890c920c426ab850df2b1fe0356a
Autor:
Michael Lock, Ronald Chow, Aruni Jayatilaka, Meghan Plotnick, Robert Stephens, Timothy Nguyen, Barbara Fisher, Eugene Wong, Stewart Gaede
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 35, Iss , Pp 17-20 (2022)
Introduction: Over the past decade, there has been a paradigm shift to higher doses per fraction of liver stereotactic body radiotherapy (SBRT). However, this shift may not be due to evidence alone, but rather result of convenience and remuneration.
Externí odkaz:
https://doaj.org/article/b823185f90a3466b9c27a1e479e16085
Autor:
Oi-Wai Chau, Omar El-Sherif, Matthew Mouawad, Jane M Sykes, John Butler, Heather Biernaski, Robert deKemp, Jennifer Renaud, Gerald Wisenberg, Frank S Prato, Stewart Gaede
Publikováno v:
PLoS ONE, Vol 18, Iss 9, p e0291854 (2023)
BackgroundLeft-sided breast cancer patients receiving adjuvant radiotherapy are at risk for coronary artery disease, and/or radiation mediated effects on the microvasculature. Previously our laboratory demonstrated in canines with hybrid 18FDG/PET a
Externí odkaz:
https://doaj.org/article/2135040d4b5b42e8994c5fc60899ca3a
Autor:
Oi-Wai Chau, BSc, Ali Islam, MD, Edward Yu, MD, Melody Qu, MD, John Butler, MRT, Heather Biernaski, MRT, Alexander Sun, MD, Jean-Pierre Bissonnette, PhD, Anna MacDonald, RN, Chantelle Graf, RN, Aaron So, PhD, Gerald Wisenberg, MD, Ting-Yim Lee, PhD, Frank S. Prato, PhD, Stewart Gaede, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 4, Pp 100927- (2022)
Externí odkaz:
https://doaj.org/article/684a2c7759364d388b568957b8185c38
Autor:
Dae-Myoung Yang, David A. Palma, Keith Kwan, Alexander V. Louie, Richard Malthaner, Dalilah Fortin, George B. Rodrigues, Brian P. Yaremko, Joanna Laba, Stewart Gaede, Andrew Warner, Richard Inculet, Ting-Yim Lee
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-8 (2021)
Abstract Background Stereotactic ablative radiation therapy (SABR) is effective in treating inoperable stage I non-small cell lung cancer (NSCLC), but imaging assessment of response after SABR is difficult. This prospective study aimed to develop a p
Externí odkaz:
https://doaj.org/article/7b32d039de8f45dca1ee9f5f9c9e0da3
Autor:
Robert Olson, Lindsay Mathews, Mitchell Liu, Devin Schellenberg, Benjamin Mou, Tanya Berrang, Stephen Harrow, Rohann J. M. Correa, Vasudeva Bhat, Howard Pai, Islam Mohamed, Stacy Miller, Famke Schneiders, Joanna Laba, Derek Wilke, Sashendra Senthi, Alexander V. Louie, Anand Swaminath, Anthony Chalmers, Stewart Gaede, Andrew Warner, Tanja D. de Gruijl, Alison Allan, David A. Palma
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background A recent randomized phase II trial evaluated stereotactic ablative radiotherapy (SABR) in a group of patients with a small burden of oligometastatic disease (mostly with 1–3 metastatic lesions), and found that SABR was associate
Externí odkaz:
https://doaj.org/article/2164cc83a76d4a73a0be273fbb56cec5
Autor:
Matthew Mouawad, Heather Biernaski, Muriel Brackstone, Michael Lock, Brian Yaremko, Olga Shmuilovich, Anat Kornecki, Ilanit Ben Nachum, Giulio Muscedere, Kalan Lynn, Frank S. Prato, R. Terry Thompson, Stewart Gaede, Neil Gelman
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 21, Iss , Pp 25-31 (2020)
Purpose: To determine the effect of dose fractionation and time delay post-neoadjuvant stereotactic ablative radiotherapy (SABR) on dynamic contrast-enhanced (DCE)-MRI parameters in early stage breast cancer patients. Materials and methods: DCE-MRI w
Externí odkaz:
https://doaj.org/article/c6cdfde672cf4c1fb301f79f275de4ae
Autor:
David A. Palma, Hanbo Chen, Houda Bahig, Stewart Gaede, Stephen Harrow, Joanna M. Laba, X. Melody Qu, George B. Rodrigues, Brian P. Yaremko, Edward Yu, Alexander V. Louie, Inderdeep Dhaliwal, Christopher J. Ryerson
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-17 (2019)
Abstract Background Stereotactic ablative radiotherapy (SABR) has become an established treatment option for medically-inoperable early-stage (Stage I-IIA) non-small cell lung cancer (ES-NSCLC). SABR is able to obtain high rates of local control with
Externí odkaz:
https://doaj.org/article/9e2d916f092b4b5eb2f0df255c4e4e56